Blockade of T‐cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV‐related HCC in mice
Yuwei Wu, Xiaolei Hao, Haiming Wei, Rui Sun, Yongyan Chen, Zhigang Tian – 7 August 2022
Issue Information
6 August 2022
Issue Information
6 August 2022
Issue Information
6 August 2022
Issue Information ‐ Author Checklist
6 August 2022
Multiomics characterization of mouse hepatoblastoma identifies yes‐associated protein 1 target genes
Tomás C. Rodríguez, Suet‐Yan Kwan, Jordan L. Smith, Sina Dadafarin, Chern‐Horng Wu, Erik J. Sontheimer, Wen Xue – 5 August 2022
Non‐transplantable recurrence after percutaneous thermal ablation of ≤3‐cm HCC: Predictors and implications for treatment allocation
Cecilia Gozzo, Margaux Hermida, Astrid Herrero, Fabrizio Panaro, Christophe Cassinotto, Azhar Meerun Mohamad, Eric Assenat, Chloé Guillot, Carole Allimant, Valentina Schembri, Antonio Basile, Sébastien Dharancy, José Ursic‐Bedoya, Boris Guiu – 5 August 2022 – Percutaneous thermal ablation (PTA), resection, and liver transplantation are the standard curative options for hepatocellular carcinoma (HCC). Liver transplantation yields the best long‐term outcomes but is limited by graft shortage.
Reply
Hang Shi, Liqing Yu – 5 August 2022
Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity
Xingfeng Liu, Kai Wang, Luhai Wang, Lijuan Kong, Shaocong Hou, Yanjun Wan, Chunxiao Ma, Jingwen Chen, Xiaowei Xing, Caiyi Xing, Qian Jiang, Qijin Zhao, Bing Cui, Zhifeng Huang, Pingping Li – 4 August 2022